Jennifer Sheng
0000-0002-3044-285X
1 paper found
Refreshing results…
Assessment of hyperprogression versus the natural course of disease development with nivolumab with or without ipilimumab versus placebo in phase III, randomized, controlled trials
Missing publications? Search for publications with a matching author name.